Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-20

Clinical Trial Update: Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updates on antineoplaston therapy for adults with anaplastic astrocytoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antineoplaston therapy (A10/AS2-1)

Snippet

Sponsor: Burzynski Research Institute | Conditions: Adult Brain Tumor | Phase 2 | Status: COMPLETED | Results posted: 2017-02-20